Mounjaro Samples: Free Trial Programs & Savings Card (2026)
Mounjaro is Eli Lilly's tirzepatide product for Type 2 diabetes — the same molecule as Zepbound but labeled and priced for diabetes care. Like every manufacturer-branded injectable in this class, "Mounjaro samples" is a high-volume search term that rarely corresponds to what the manufacturer actually gives away.
In 2026, the real Mounjaro access story is about four levers: the Lilly savings card that most commercially insured diabetes patients can use, the narrower LillyDirect cash-pay channel, the specific telehealth providers that have clean Mounjaro prior-authorization workflows, and compounded tirzepatide as a cash-pay fallback for patients where the diagnosis or plan coverage doesn't line up.
This guide covers every legitimate 2026 path to Mounjaro, real pricing across each channel, and which providers in our ranking specifically handle the diabetes-indication workflow rather than the weight-management workflow.
What's actually available: Mounjaro samples in 2026
Three paths for people typing “mounjarosamples” — what they actually mean, typical cost, and who each path fits.
| Path | What it actually is | Typical cost | Best for |
|---|---|---|---|
| Mounjaro savings card | Manufacturer copay assistance for commercially insured Type 2 diabetes patients. | $25 / 28-day supply | Insured diabetes patients whose plan covers Mounjaro |
| Telehealth + retail pharmacy | Async consult, Rx to a local pharmacy, paid with savings card plus insurance. | $49–$99 consult + drug cost | Patients who don't have a diabetes specialist and need a fast start |
| Compounded tirzepatide | Not Mounjaro — same molecule from a licensed compounding pharmacy, narrower post-2024 availability. | $249–$449 / month all-in | Cash-pay patients where Mounjaro's commercial channels don't fit |
How Mounjaro sample programs actually work
The Mounjaro savings card in 2026
The Lilly Mounjaro savings card is functionally identical to the Zepbound card but runs against the diabetes indication. Commercially insured patients whose plan covers Mounjaro pay $25 per 28-day supply. Commercially insured patients whose plan does not cover Mounjaro pay a flat $573 under the card — still a meaningful discount off retail. Federal plan enrollees (Medicare Part D, Medicaid, VA, Tricare) cannot use the card.
Why LillyDirect doesn't sell consumer-price Mounjaro
LillyDirect's aggressive cash-pay vial pricing is specific to Zepbound — the obesity-indication product. Lilly has not extended the same cash channel to Mounjaro, likely because Mounjaro's Medicare Part D and commercial coverage for diabetes is far better than Wegovy/Zepbound's coverage for obesity, so there's less strategic reason to subsidize cash-pay shoppers.
Telehealth for fast Mounjaro initiation
For patients with a current Type 2 diabetes diagnosis who want a same-week start, telehealth providers like Ro, Sesame, and Mochi complete intake in 24–72 hours and can use the Lilly savings card at a retail pharmacy fulfillment. Expect a $49–$99 consult fee plus drug cost after the card. Not every telehealth provider handles diabetes — many are obesity-focused — so confirm the indication fits before paying.
When compounded tirzepatide still makes sense
Compounded tirzepatide has narrower availability in 2026 than it did in 2024, but it remains viable for specific patient situations: diabetes patients whose plan doesn't cover Mounjaro, patients experiencing recurrent supply hiccups at retail, and patients whose clinician specifically wants non-standard dosing. Reputable 503A/503B pharmacies run $249–$449/month all-in. Verify the state board license for any pharmacy under consideration.
If you have Type 2 diabetes and commercial insurance, the Mounjaro savings card is quietly the best deal in the entire GLP-1 category.
Top providers offering Mounjaro or the compounded alternative
Providers we've verified currently support a clinically appropriate Mounjaro path. Pricing and availability vary by state. Every link is an affiliate link tracked through Impact Engine — see our disclosure.
| Rank | Provider | Best for | Sample type | Editor | Readers | Action |
|---|---|---|---|---|---|---|
| #1 | Henry Meds Compounded Semaglutide · Compounded Tirzepatide | best-for-compounded | telehealth | 4.6 / 5 | — | See offer |
| #2 | Mochi Health Compounded Semaglutide · Compounded Tirzepatide | best-for-clinical-support | telehealth | 4.4 / 5 | — | See offer |
| #3 | Ro Body Semaglutide · Tirzepatide | best-for-branded-rx | telehealth | 4.3 / 5 | — | See offer |
| #4 | Sesame Care Semaglutide · Tirzepatide | best-for-one-time-visit | telehealth | 4.2 / 5 | — | See offer |
| #5 | Found Semaglutide · Tirzepatide | best-for-insurance-coverage | telehealth | 4.0 / 5 | — | See offer |
| #6 | LifeMD Semaglutide · Tirzepatide | best-for-regulated-provider | telehealth | 4.0 / 5 | — | See offer |
| #7 | WeightWatchers Clinic Semaglutide · Tirzepatide | best-for-lifestyle-bundle | telehealth | 3.9 / 5 | — | See offer |
Henry Meds
Flat-rate compounded GLP-1 with a free telehealth consult to see if you qualify.
- ✓ Free intake consult
- ✓ Flat monthly price, no insurance needed
- ✓ No long-term contract
- − Not available in all states
- − Supply constraints during GLP-1 shortages
- − Compounded only (no branded Ozempic/Wegovy)
Mochi Health
Compounded GLP-1 with a dietitian-led program and insurance-billing option.
- ✓ Includes dietitian visits
- ✓ Insurance billing available
- ✓ Strong clinical team
- − Higher price than cash-only peers
- − Intake can take several days
- − US only
Ro Body
Major branded-Rx telehealth with a dedicated GLP-1 weight-loss program.
- ✓ Branded Wegovy / Zepbound when available
- ✓ Insurance coordination support
- ✓ Established national brand
- − Higher monthly cost
- − Intake and shipping slower than lean competitors
- − Not all medications in stock in all states
Sesame Care
A la carte telehealth where you pay per visit and get real GLP-1 prescriptions at list pricing.
- ✓ No subscription or recurring fee
- ✓ Pay once for the consult
- ✓ Use your own pharmacy + GoodRx
- − Medication cost is separate
- − No built-in coaching or support
- − Availability varies by state
Found
Weight-loss program that coordinates branded and compounded GLP-1 based on what your insurance covers.
- ✓ Handles prior authorizations
- ✓ Branded or compounded based on coverage
- ✓ Integrated coaching
- − Cost higher than cash-only peers
- − PA process can take weeks
- − Program requires 3-month commitment
Mounjaro cost in 2026: every legitimate price path
What you'll actually pay depends on insurance, the path you take, and whether you stay on the brand-name drug. Here's the real money:
| Path | First month | Ongoing | Notes |
|---|---|---|---|
| Savings card (covered commercial plan) | $25 | $25/mo until annual cap | Requires PA in some plans; federal plans excluded. |
| Savings card (uncovered commercial) | $573 | $573/mo | Flat discount off retail for commercially insured, non-covered. |
| Retail cash price | $1,069 | $1,069/mo | Pen formulation without insurance or manufacturer card. |
| Compounded tirzepatide | $249–$349 | $349–$449/mo | Cash-pay; narrowing post-shortage market. |
What to expect on Mounjaro: your first weeks
Mounjaro uses the same titration schedule as Zepbound: 2.5 mg weekly for 4 weeks, then step up to 5, 7.5, 10, 12.5, and 15 mg monthly. For diabetes management specifically, many clinicians stabilize patients at 5–10 mg based on A1C response rather than pushing to the maximum dose.
A1C response on tirzepatide is faster and larger than semaglutide's. Expect measurable A1C reduction at 8–12 weeks; the SURPASS program showed 2.0–2.3 percentage point reductions at higher doses.
GI side effects cluster at dose escalations. Clinicians managing diabetes often pause titration at the first sign of persistent nausea rather than pushing through — reaching the maximum dose isn't the goal when A1C is already controlled.
Clinical evidence behind Mounjaro
Mounjaro received FDA approval in May 2022 based on the SURPASS clinical trial program. In SURPASS-2, tirzepatide 15 mg reduced A1C by 2.46 percentage points over 40 weeks compared to 1.86 for semaglutide 1.0 mg — the first head-to-head showing a GLP-1/GIP agonist outperforming semaglutide in diabetes care. Weight loss in diabetes patients on tirzepatide averaged 9.5–11.7 kg at higher doses.
Mounjaroside effects & who shouldn't take it
This is not medical advice. Discuss every medication decision with a licensed clinician who knows your full medical history.
Common side effects
- •Nausea, peaking at dose escalations
- •Diarrhea, constipation, or alternation
- •Vomiting, especially at the 5 mg and 7.5 mg steps
- •Decreased appetite
- •Injection-site reactions
- •Rare but serious: pancreatitis, gallbladder disease, MTC boxed warning
Who shouldn't take Mounjaro
- •Personal or family history of medullary thyroid carcinoma
- •Multiple endocrine neoplasia syndrome type 2
- •Type 1 diabetes (Mounjaro is not approved for this indication)
- •History of severe pancreatitis
- •Pregnancy or planned pregnancy within 2 months
Eligibility for Mounjaro
- •Adults with a Type 2 diabetes diagnosis
- •Commercial insurance for savings card eligibility; federal plans excluded
- •Clinician-led titration schedule
- •Not required: specific BMI — this is a diabetes drug, not a weight drug
Mounjaro samples: frequently asked
Are Mounjaro samples actually free?
Lilly does not distribute consumer-facing free Mounjaro samples. The savings card ($25/month for eligible insured diabetes patients) is the closest consumer-accessible equivalent.
Is Mounjaro the same as Zepbound?
Same molecule (tirzepatide), different FDA labels and pricing. Mounjaro is approved for Type 2 diabetes; Zepbound is approved for chronic weight management. They are not interchangeable at the pharmacy.
Can I get Mounjaro for weight loss?
Mounjaro is not FDA-approved for weight loss. Some clinicians prescribe it off-label when a patient has both diabetes and obesity. For weight loss specifically without diabetes, Zepbound is the correct Lilly product.
How much is Mounjaro without insurance?
Retail cash price is around $1,069 per 28-day supply. The savings card can reduce this to ~$573/month for commercially insured patients without coverage. Fully uninsured patients may qualify for Lilly's Patient Assistance Program separately.
Does Medicare cover Mounjaro?
Medicare Part D plans often cover Mounjaro for Type 2 diabetes, though coverage and copays vary by plan. Manufacturer copay cards cannot be used with Medicare by federal statute.
How fast can I start Mounjaro?
Telehealth providers can complete intake in 24–72 hours. Pharmacy fulfillment depends on prior-authorization cycles — 3 days in the best case, 2–3 weeks in the harder cases. Patients with an established diabetes diagnosis and a covering commercial plan see the fastest starts.
Is compounded tirzepatide legal for diabetes patients?
Compounded tirzepatide is prepared against an individual prescription at a licensed 503A or 503B pharmacy. Since FDA's October 2024 removal of tirzepatide from the shortage list, the legal basis for large-scale compounded production has narrowed. Individual compounding under 503A and 503B outsourcing under specific clinical justification continue.
What's the difference between Mounjaro and Ozempic?
Different molecules. Mounjaro is tirzepatide (GLP-1 + GIP dual agonist). Ozempic is semaglutide (GLP-1 only). In head-to-head trials, tirzepatide showed larger A1C and weight reductions than semaglutide. Both are approved for Type 2 diabetes.
How long do I stay on Mounjaro?
Mounjaro is a chronic therapy for Type 2 diabetes. Discontinuation typically results in A1C and weight returning toward baseline. Duration is a decision for you and your prescribing clinician based on response and tolerability.
Are there coupons for Mounjaro besides the Lilly card?
GoodRx and similar pharmacy discount services offer modest additional savings in specific pharmacies, but the Lilly savings card is generally the largest consumer-facing discount available.